Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 9, 2012
Early endpoints for acute bacterial skin and skin structure infections
George L Drusano
The Journal of Antimicrobial Chemotherapy
|
April 13, 2011
What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
George L Drusano
Current Opinion in Pharmacology
|
October 17, 2017
Pre-clinical in vitro infection models
George L Drusano
The Journal of Infectious Diseases
|
May 6, 2017
Stepping Off the Resistance Treadmill
George L Drusano
Nature Reviews. Microbiology
|
March 20, 2004
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
George L Drusano
Pharmacotherapy
|
November 25, 2005
Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics
George L Drusano
The Journal of Antimicrobial Chemotherapy
|
December 1, 2010
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity
George L Drusano
Antiviral Chemistry & Chemotherapy
|
May 14, 2011
Antiviral pharmacodynamics in hollow fibre bioreactors
James J McSharry, George L Drusano
The Journal of Antimicrobial Chemotherapy
|
August 6, 2016
Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality
William Hope, George L Drusano, John H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 6, 2007
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy
Thomas P Lodise, Ben Lomaestro, George L Drusano
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
Antimicrobial Agents and Chemotherapy
|
February 9, 2012
Early endpoints for acute bacterial skin and skin structure infections
George L Drusano
The Journal of Antimicrobial Chemotherapy
|
April 13, 2011
What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
George L Drusano
Current Opinion in Pharmacology
|
October 17, 2017
Pre-clinical in vitro infection models
George L Drusano
The Journal of Infectious Diseases
|
May 6, 2017
Stepping Off the Resistance Treadmill
George L Drusano
Nature Reviews. Microbiology
|
March 20, 2004
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
George L Drusano
Pharmacotherapy
|
November 25, 2005
Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics
George L Drusano
The Journal of Antimicrobial Chemotherapy
|
December 1, 2010
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity
George L Drusano
Antiviral Chemistry & Chemotherapy
|
May 14, 2011
Antiviral pharmacodynamics in hollow fibre bioreactors
James J McSharry, George L Drusano
The Journal of Antimicrobial Chemotherapy
|
August 6, 2016
Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality
William Hope, George L Drusano, John H Rex
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 6, 2007
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy
Thomas P Lodise, Ben Lomaestro, George L Drusano
Page
of 16